Abstract C064: Tumor Ecosystem and Microbiome Features Associated with Efficacy from Avelumab-based Multimodal Therapy in a Phase III Randomized Trial
Year: 2026
Type: conference-abstract
Source: Cancer Immunology Research
Authors: Tyler Alban, Nadeem Riaz, Robert Haddad, Michelle Saul, Vladamir Makarov, Yingjie Zhu, Ezra Cohen, Robert Ferris, Peter Chang, Jin-Ching Lin, Amanda Pyrri, Prerana Parthasarathy, Ardijana Novaj, Mruniya Gawali, Jennifer Ko, Phineas Hamilton, Natalie Silver, Ivan Juric, Daniel Chawla, Ana Gradissimo, Daniel McGrail, Craig Davis, Nancy Lee, Timothy Chan
Institutions: Cleveland Clinic, Memorial Sloan Kettering Cancer Center, Pfizer (United States), University of California San Diego, UPMC Health System, University of Pittsburgh Medical Center, Taipei Veterans General Hospital, Changhua Christian Hospital, National and Kapodistrian University of Athens
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7130418559
Cites:
Cited by:
Related to: